# Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases

> **NCT03540823** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 300 (actual)

## Conditions studied

- Systemic Lupus
- Sjogren's Syndrome

## Interventions

- **BIOLOGICAL:** Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus; B / Phuket / 3073/2013-like virus)

## Key facts

- **NCT ID:** NCT03540823
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2018-06-23
- **Final completion:** 2018-08-23
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03540823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03540823, "Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT03540823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*